Daiichi Sankyō logo

Daiichi Sankyō

DSNKY · OTC · Pharmaceuticals, Biotech · Founded 2005

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin.

Current Price
$18.15
Market Cap
$33.4B
Return Since Last Split
-34%
Last Split
Oct 9, 2020
Total Splits
1
Cumulative Multiple
3×

What If You Bought DSNKY Earlier?

Investment
Purchase Date (Before Split)
Worth Today
$5,445
300 shares · 3×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
Oct 9, 2020$28.383-for-13×3×

Daiichi Sankyō Market Cap Timeline

Validated annual market-cap history is available from 2004. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Frequently Asked Questions

Daiichi Sankyō's latest record in the split calendar is a 3-for-1 forward split effective 2020-10-09.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.